Publications by authors named "G Caocci"

Claim this Profile
H
Health-related quality of life and symptom profile of patients with -negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational study.
Giovanni Caocci, Alessandro Costa, Francesca Palandri, Paola Guglielmelli, Andrea Patriarca

Hemasphere· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.
Fausto Castagnetti, Massimo Breccia, Elisabetta Abruzzese, Renato Bassan, Gianni Binotto, Giovanni Caocci

Leukemia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study.
Anna Sicuranza, Paola Pacelli, Adele Santoni, Elisabetta Abruzzese, Daniele Cattaneo, Giovanni Caocci

Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib.
Francesca Palandri, Filippo Branzanti, Massimiliano Bonifacio, Elena M Elli, Erika Morsia, Giovanni Caocci

Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial.
Fabio Efficace, Laura Cannella, Isabella Capodanno, Rosaria Sancetta, Veronica Porcu, Giovanni Caocci

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis